FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $21,267,000 | -59.1% | 619,855 | -73.5% | 1.57% | -71.1% |
| Q1 2020 | $52,013,000 | +488.8% | 2,341,875 | +418.9% | 5.43% | +582.7% |
| Q4 2019 | $8,833,000 | -1.4% | 451,354 | -80.1% | 0.80% | -33.3% |
| Q3 2017 | $8,960,000 | +9.0% | 2,262,678 | -10.8% | 1.19% | -18.2% |
| Q2 2017 | $8,220,000 | -28.8% | 2,537,026 | 0.0% | 1.46% | -50.0% |
| Q1 2017 | $11,543,000 | +526.7% | 2,537,026 | +329.6% | 2.92% | +416.5% |
| Q3 2016 | $1,842,000 | – | 590,527 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |